Current and Emerging Perspectives in the Diagnosis and Management of Adult Glioblastoma.

When
04 Oct 2012
6:00 PM - 8:30 PM
Location
Midwest Cancer Center - 172nd and Wright St.

Registration

General - Free
General registration is open to specialists such as neurologists, neurosurgeons, and those working in the field of neuro-oncology.
Gold Corporate Member - $125.00 (USD)
NOS Member - Free
Platinum Corporate Member - Free

Registration is closed

PLEASE JOIN US FOR A FREE CONTINUING EDUCATIONAL EVENT AT MIDWEST CANCER CENTER ON THURSDAY, OCTOBER 4TH...

Guest Speaker: Jeffrey J. Raizer, MD, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois

The lecture will be certified for physician, nurse, and pharmacist continuing education credit. This activity is sponsored by RMEI and Postgraduate Institute for Medicine (CME provider)and is supported by an educational grant from Genentech.

The learning objectives for this activity is listed below:

1. Describe prognostic factors in the survival of adults with glioblastoma

2. Identify molecular and genetic biomarkers associated with response to treatment

3. Summarize the strengths and limitations of current treatments for newly diagnosed and recurrent glioblastoma

4. Identify emerging targeted treatment alternatives that have demonstrated favorable results in glioblastoma

Nebraska Oncology Society
Midwest Cancer Center
7500 Mercy Road, Suite 1300
Omaha, NE 68124
Attn: Natalie Mandolfo; Papillion Office

Telephone (402) 690-1397
Fax (402) 593-3145

NOS@COX.NET

Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds